Gerresheimer announced on 29 July 2026 that it is selling two businesses to Apax Funds: Centor, and its global Primary Packaging Plastics operation. Source: the company's own release at https://www.gerresheimer.com/en/customer/company/news/detail/gerresheimer-is-selling-centor-and-its-global-primary-packaging-plastics-business-to-apax-funds, with same-week coverage in Packaging Europe and Packaging Dive.
The combined enterprise value is approximately €1.5 billion. The Centor sale is expected to close by the end of financial year 2026, and the Primary Packaging Plastics sale in the first half of financial year 2027.
This is a packaging trade story, which is why most beauty founders will never see it. It is also, in a slow and unglamorous way, a story about your cost of goods eighteen months from now.
Why an ownership change at the supply end reaches you at all
Primary packaging is the container that touches the product. For a beauty brand that is the tube, the jar, the pump bottle, the dropper, the closure. It is the component with the longest lead time, the highest tooling cost, and the least flexibility once you have committed to a format.
Most small brands do not buy this directly from the manufacturer. They buy through a contract manufacturer, a packaging distributor, or a sourcing agent, which means the actual producer is often two steps removed and rarely named on any document the founder sees.
That distance is why supply-side consolidation arrives silently. There is no announcement to you. There is a quote that comes back higher, or a lead time that has quietly moved from ten weeks to fifteen, or a component that is suddenly listed as unavailable in your colour.
What private-equity ownership usually changes
This is not a claim about Apax specifically, and it is not a prediction about what these two businesses will do. It is a description of what typically happens when packaging capacity moves into private-equity hands, and what a prudent operator plans for.
Portfolios get rationalised. Long-tail formats and low-volume variants that sit in a catalogue without earning their keep tend to get discontinued. If your product sits on a slightly unusual jar or an uncommon neck finish, that is the sort of component that quietly disappears from a rationalised range.
Minimum order quantities get enforced. Capacity gets pointed at the customers who fill it most efficiently, which means the large pharmaceutical and FMCG accounts rather than the beauty brand ordering thirty thousand units.
Pricing gets re-tiered. Volume bands get redrawn, and brands sitting just below a threshold can find themselves paying meaningfully more per unit for the same component.
None of this is hostile. It is ordinary commercial discipline. It just lands unevenly, and the brands with the least leverage feel it first.
The three questions most founders cannot answer about their own packaging
Ask a founder at £500k-£5m these three and watch what happens.
Who actually manufactures your primary packaging? Not who invoices you. Who makes it. A surprising number of founders do not know, because the relationship is intermediated and the question has never mattered before.
What is your real lead time from order to delivery, including tooling and any colour-matching cycle? Most founders quote the number their supplier gave them once, not the number their last three orders actually took.
If your current component became unavailable tomorrow, what would you switch to, and would it fit your existing filling line and your existing carton? This is the one that exposes real risk, because the answer for a lot of brands is that they have never checked, and a substitute with a different neck finish or a different height means new tooling, new artwork and a new carton.
You do not need to fix all three this week. You need to be able to answer them, because you cannot manage exposure you have not written down.
Single-sourcing is the actual risk, not price
Price increases are annoying. They are survivable, and they can be passed through or absorbed.
The risk that genuinely damages a small beauty brand is a component becoming unavailable with no drop-in substitute. That is a stock-out on your best-selling SKU, at whatever moment it happens to occur, with no ability to shorten the timeline because tooling takes what tooling takes.
The defensive move is not to hold twelve months of packaging stock, which ties up cash you need elsewhere. It is to know, for each of your top SKUs, what the alternative component is and whether it drops in without a line change or an artwork rebuild.
For components where a drop-in substitute exists, your exposure is a price negotiation. For components where it does not, your exposure is your whole SKU. Those are completely different risks and they deserve completely different amounts of attention.
What good looks like at this size
A brand doing this properly does not have a procurement function. It has a spreadsheet.
One row per packaging component across the top SKUs. Columns for the supplier you buy from, the manufacturer behind them, current unit cost, current MOQ, current real lead time, and a named alternative component with a note on whether it fits the existing line. Reviewed twice a year, and re-quoted at least annually.
That is perhaps a day of work to build and an hour twice a year to maintain. It is the difference between finding out about a supply change through a quote and finding out through a stock-out.
The other habit worth building is simply asking. When you next speak to your contract manufacturer or packaging distributor, ask directly whether any of your components are affected by ownership changes upstream, and whether any formats in the range you buy from are being discontinued. Suppliers generally answer that question honestly when it is asked. They very rarely volunteer it.
The unglamorous conclusion
Beauty founders spend enormous attention on the things customers see and very little on the things that determine whether the product exists at all. Packaging sits in the second category until the week it does not.
A €1.5 billion change of ownership in cosmetics packaging supply is not going to change your business this quarter. It is the kind of thing that shows up in your cost of goods and your lead times over the following year or two, quietly, without a headline attached.
The brands that handle it well will be the ones who already knew what they were buying and from whom. That knowledge is cheap to acquire right now and expensive to acquire under pressure.